Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YSG
3076
Yatsen Holding
YSG
$322M
| $1.48M | ﹤0.01% |
162,820
+27,628
| +20% | +$263K |
|
3077
Root
ROOT
$857M
| $1.47M | ﹤0.01% |
16,451
-8,681
| -35% | -$910K |
|
3078
CALL
Roivant Sciences
ROIV
$24.5B
| $1.47M | ﹤0.01% |
+97,300
| New | +$1.2M |
|
3079
PUT
Xerox
XRX
$387M
| $1.47M | ﹤0.01% |
390,000
+342,500
| +721% | +$1.51M |
|
3080
PUT
Zillow
Z
$7.79B
| $1.46M | ﹤0.01% |
19,000
| – | – |
|
3081
Cohu
COHU
$2.26B
| $1.46M | ﹤0.01% |
71,930
-15,188
| -17% | -$306K |
|
3082
iShares MSCI China ETF
MCHI
$6.32B
| $1.46M | ﹤0.01% |
22,177
+5,466
| +33% | +$328K |
|
3083
PUT
YPF
YPF
$206B
| $1.46M | ﹤0.01% |
+60,000
| New | +$1.84M |
|
3084
Transcat
TRNS
$799M
| $1.45M | ﹤0.01% |
19,833
+2,240
| +13% | +$181K |
|
3085
Cable One
CABO
$227M
| $1.45M | ﹤0.01% |
8,191
-2,615
| -24% | -$393K |
|
3086
CALL
CleanSpark
CLSK
$3.53B
| $1.45M | ﹤0.01% |
100,000
-100,000
| -50% | -$1.13M |
|
3087
Navigator Holdings
NVGS
$1.38B
| $1.45M | ﹤0.01% |
93,571
+22,427
| +32% | +$358K |
|
3088
Arvinas
ARVN
$518M
| $1.45M | ﹤0.01% |
169,969
-50,864
| -23% | -$386K |
|
3089
Enliven Therapeutics
ELVN
$3.92B
| $1.45M | ﹤0.01% |
70,689
-2,095
| -3% | -$42.2K |
|
3090
Carter's
CRI
$1.42B
| $1.45M | ﹤0.01% |
51,274
-29,643
| -37% | -$850K |
|
3091
Rigel Pharmaceuticals
RIGL
$681M
| $1.45M | ﹤0.01% |
51,065
-8,741
| -15% | -$261K |
|
3092
Domo
DOMO
$174M
| $1.45M | ﹤0.01% |
91,309
-25,595
| -22% | -$396K |
|
|
HPP
3093
Hudson Pacific Properties
HPP
$747M
| $1.45M | ﹤0.01% |
74,837
-1,483
| -2% | -$28K |
|
3094
Washington Trust Bancorp
WASH
$743M
| $1.44M | ﹤0.01% |
49,886
-15,087
| -23% | -$436K |
|
|
CSR
3095
Centerspace
CSR
$921M
| $1.44M | ﹤0.01% |
24,462
-33,655
| -58% | -$1.94M |
|
|
AXON
3096
CALL
Axon Enterprise
AXON
$42.5B
| $1.44M | ﹤0.01% |
2,000
| – | – |
|
3097
CALL
The GEO Group
GEO
$4.13B
| $1.43M | ﹤0.01% |
70,000
| – | – |
|
|
3098
PUT
The GEO Group
GEO
$4.13B
| $1.43M | ﹤0.01% |
70,000
| – | – |
|
3099
Worthington Steel
WS
$1.83B
| $1.43M | ﹤0.01% |
47,019
-14,671
| -24% | -$468K |
|
3100
Blend Labs
BLND
$431M
| $1.43M | ﹤0.01% |
391,202
-125,840
| -24% | -$452K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.